When healthy cells stimulate the migration of tumor cells

June 15, 2017
Left: Cells carrying the traditional GPER (fluorescent cytoplasm). Right: Cells carrying the nuclear variant of GPER (fluorescent nucleus). Credit: Université de Genève

Estrogens act as a driving force of both healthy and cancerous mammary cell growth by binding to receptors that include a type named GPER, which is generally located in cell membranes. Recent studies have, however, revealed the unusual presence of this receptor in the nuclei of fibroblasts - cells of the connective tissue - surrounding mammary tumor cells. Researchers at the University of Geneva (UNIGE), Switzerland, have discovered that this is in fact another version of GPER, a nuclear variant of this receptor, with different properties. The fibroblasts carrying this variant promote the migration of neighboring malignant cells, thus participating in the process of tumor metastasis. This research, which may pave the way to a novel therapeutic strategy, is published in the journal Oncotarget.

Estrogens play a crucial role in the genesis of the majority of breast cancers, promoting the survival, proliferation and invasiveness of tumor . These hormones act by binding to their receptors, which fall into two groups, ER and GPER, whose properties differ.

The team of Didier Picard, professor at the Department of Cell Biology of the Faculty of Sciences of UNIGE, is interested in GPER receptors, whose effects on breast cancer are less well known than those of the ER family. "By analyzing a breast tumor biopsy, our colleagues at the University of Calabria, who participated in this study, discovered GPER receptors in the nucleus of fibroblasts present around the malignant cells, whereas they had always been localized elsewhere before", says the biologist.

Fibroblasts abound around the tumor

Fibroblasts, constituents of the , are part of the microenvironment of the tumors. "Knowing that cancer cells interact with neighboring healthy cells to survive and grow, we wanted to find out whether the GPER receptors observed in the nucleus of these fibroblasts were involved in this process", explains Marco Pupo, first author of the study.

The researchers have discovered the existence of another version of GPER: "This genetic variant results from a tiny change, a single nucleotide, in the gene that codes for the GPER receptor. This is sufficient to induce its relocation to the nucleus. We detected the presence of this same version of the gene in the fibroblasts of the eight other biopsies we analyzed, from the University Hospital of Geneva", states Didier Picard.

The genetic variant of GPER could predispose to breast cancer

The nuclear variant also acquires new properties. Indeed, unlike the GPER receptor hitherto described, it is capable of stimulating the expression of genes involved in malignant growth. Moreover, present in the microenvironment and carrying nuclear GPER secrete molecules that promote the migration of neighboring .

"We have deciphered an important element of the dialogue between the and the adjacent healthy cells, and we want to find out the nature of the fibroblastic factors involved in the process of ", specifies Marco Pupo. It may be worth thinking about specifically interfering with the nuclear functions of GPER as a novel therapeutic strategy.

Explore further: Understanding the resistance to treatments against breast cancer

More information: Marco Pupo et al. A genetic polymorphism repurposes the G-protein coupled and membrane-associated estrogen receptor GPER to a transcription factor-like molecule promoting paracrine signaling between stroma and breast carcinoma cells, Oncotarget (2017). DOI: 10.18632/oncotarget.18156

Related Stories

Understanding the resistance to treatments against breast cancer

June 20, 2016
Estrogens are responsible for the survival and proliferation of tumor cells in 70% of all breast cancer cases. The most frequently used treatment to fight this variety of tumors relies on anti-estrogens such as tamoxifen. ...

Gene variant identified as a heart disease risk factor for women

July 22, 2014
When it comes to heart disease, Dr. Ross Feldman says women are often in the dark. Historically, it was thought that heart disease was a men's-only disease, however, data has shown that post-menopausal women are just as likely ...

Researchers identify estrogen's role in regulating common health disease risks

November 13, 2014
What makes some women more susceptible to heart disease than others? To help answer that question, researchers at Western University's Robarts Research Institute have identified that an estrogen receptor, previously shown ...

Researchers describe how tumors recruit and use stem cells to support tumor growth and progression

October 20, 2016
A new study has identified a mechanism used by tumors to recruit stem cells from bone and convert them into cancer-associated fibroblasts (CAFs) that facilitate tumor progression. This work, which pinpoints the specific biochemical ...

Researchers discover tumor cells stiffen before becoming invasive

May 16, 2017
A study recently published in Nature Communications shows that breast cancer cells undergo a stiffening state prior to becoming malignant. The discovery, made by a research team led by Florence Janody, from Instituto Gulbenkian ...

Study reveals how normal cells fuel tumor growth

December 21, 2011
A new study published in the journal Nature Cell Biology has discovered how normal cells in tumors can fuel tumor growth.

Recommended for you

Outdoor light at night linked with increased breast cancer risk in women

August 17, 2017
Women who live in areas with higher levels of outdoor light at night may be at higher risk for breast cancer than those living in areas with lower levels, according to a large long-term study from Harvard T.H. Chan School ...

Scientists develop novel immunotherapy technology for prostate cancer

August 17, 2017
A study led by scientists at The Wistar Institute describes a novel immunotherapeutic strategy for the treatment of cancer based on the use of synthetic DNA to directly encode protective antibodies against a cancer specific ...

Toxic formaldehyde is produced inside our own cells, scientists discover

August 16, 2017
New research has revealed that some of the toxin formaldehyde in our bodies does not come from our environment - it is a by-product of an essential reaction inside our own cells. This could provide new targets for developing ...

Cell cycle-blocking drugs can shrink tumors by enlisting immune system in attack on cancer

August 16, 2017
In the brief time that drugs known as CDK4/6 inhibitors have been approved for the treatment of metastatic breast cancer, doctors have made a startling observation: in certain patients, the drugs—designed to halt cancer ...

Researchers find 'switch' that turns on immune cells' tumor-killing ability

August 16, 2017
Molecular biologists led by Leonid Pobezinsky and his wife and research collaborator Elena Pobezinskaya at the University of Massachusetts Amherst have published results that for the first time show how a microRNA molecule ...

Popular immunotherapy target turns out to have a surprising buddy

August 16, 2017
The majority of current cancer immunotherapies focus on PD-L1. This well studied protein turns out to be controlled by a partner, CMTM6, a previously unexplored molecule that is now suddenly also a potential therapeutic target. ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.